Dr. Dan Selchen discusses new insights into early diagnosis of MS and assessing a patient’s long-term prognosis while at ECTRIMS 2015 in Barcelona, Spain.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Dr. Dan Selchen discusses new insights into early diagnosis of MS and assessing a patient’s long-term prognosis while at ECTRIMS 2015 in Barcelona, Spain.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Release Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!